Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study

<p>This study aimed to assess the differential effects of first-generation (FGA) and second-generation antipsychotics (SGA) on the prevalence of risk factors for metabolic syndrome among mentally ill patients in Qatar. We also wanted to check if there is proper adherence with the guidelines fo...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Samer Hammoudeh (3095097) (author)
مؤلفون آخرون: Hawra Al Lawati (14150979) (author), Suhaila Ghuloum (796180) (author), Huma Iram (9617384) (author), Arij Yehya (3095079) (author), Imen Becetti (9617366) (author), Nora Al-fakhri (14150982) (author), Hany Ghabrash (9617372) (author), Mena Shehata (9617369) (author), Nighat Ajmal (9617387) (author), Iman Amro (13996378) (author), Hira Safdar (14150985) (author), Yassin Eltorki (9617390) (author), Hassen Al-Amin (3095082) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513567911313408
author Samer Hammoudeh (3095097)
author2 Hawra Al Lawati (14150979)
Suhaila Ghuloum (796180)
Huma Iram (9617384)
Arij Yehya (3095079)
Imen Becetti (9617366)
Nora Al-fakhri (14150982)
Hany Ghabrash (9617372)
Mena Shehata (9617369)
Nighat Ajmal (9617387)
Iman Amro (13996378)
Hira Safdar (14150985)
Yassin Eltorki (9617390)
Hassen Al-Amin (3095082)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Samer Hammoudeh (3095097)
Hawra Al Lawati (14150979)
Suhaila Ghuloum (796180)
Huma Iram (9617384)
Arij Yehya (3095079)
Imen Becetti (9617366)
Nora Al-fakhri (14150982)
Hany Ghabrash (9617372)
Mena Shehata (9617369)
Nighat Ajmal (9617387)
Iman Amro (13996378)
Hira Safdar (14150985)
Yassin Eltorki (9617390)
Hassen Al-Amin (3095082)
author_role author
dc.creator.none.fl_str_mv Samer Hammoudeh (3095097)
Hawra Al Lawati (14150979)
Suhaila Ghuloum (796180)
Huma Iram (9617384)
Arij Yehya (3095079)
Imen Becetti (9617366)
Nora Al-fakhri (14150982)
Hany Ghabrash (9617372)
Mena Shehata (9617369)
Nighat Ajmal (9617387)
Iman Amro (13996378)
Hira Safdar (14150985)
Yassin Eltorki (9617390)
Hassen Al-Amin (3095082)
dc.date.none.fl_str_mv 2022-11-22T21:13:03Z
dc.identifier.none.fl_str_mv 10.1007/s10597-019-00537-y
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Risk_Factors_of_Metabolic_Syndrome_Among_Patients_Receiving_Antipsychotics_A_Retrospective_Study/21597216
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Clinical sciences
Public health
Psychiatry and Mental health
Public Health, Environmental and Occupational Health
Health (social science)
dc.title.none.fl_str_mv Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p>This study aimed to assess the differential effects of first-generation (FGA) and second-generation antipsychotics (SGA) on the prevalence of risk factors for metabolic syndrome among mentally ill patients in Qatar. We also wanted to check if there is proper adherence with the guidelines for prescribing antipsychotics and the monitoring of metabolic effects in this population. We collected the available retrospective data (socio-demographic, psychiatric, anthropometric, and metabolic measures) from the records of 439 patients maintained on antipsychotics. The majority were males, married, employed, having a psychotic disorder, and receiving SGA. Patients on SGA showed more obesity, higher BP, and more elevated triglycerides compared to those on FGA. The prevalence of the abnormal metabolic measures was high in this sample, but those on SGA showed a significantly higher prevalence of abnormal body mass index and BP. Obesity and hypertension were common in patients maintained on antipsychotics, especially those on SGA. Polypharmacy was common, and many metabolic measures were not monitored properly in those maintained on antipsychotics. More prospective studies with guided monitoring of the patients' clinical status and metabolic changes are needed to serve better this population of patients.</p><h2>Other Information</h2> <p> Published in: Community Mental Health Journal<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s10597-019-00537-y" target="_blank">http://dx.doi.org/10.1007/s10597-019-00537-y</a></p>
eu_rights_str_mv openAccess
id Manara2_b6e6c5f1c5dd8a0e8979c61bf8c96078
identifier_str_mv 10.1007/s10597-019-00537-y
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/21597216
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective StudySamer Hammoudeh (3095097)Hawra Al Lawati (14150979)Suhaila Ghuloum (796180)Huma Iram (9617384)Arij Yehya (3095079)Imen Becetti (9617366)Nora Al-fakhri (14150982)Hany Ghabrash (9617372)Mena Shehata (9617369)Nighat Ajmal (9617387)Iman Amro (13996378)Hira Safdar (14150985)Yassin Eltorki (9617390)Hassen Al-Amin (3095082)Clinical sciencesPublic healthPsychiatry and Mental healthPublic Health, Environmental and Occupational HealthHealth (social science)<p>This study aimed to assess the differential effects of first-generation (FGA) and second-generation antipsychotics (SGA) on the prevalence of risk factors for metabolic syndrome among mentally ill patients in Qatar. We also wanted to check if there is proper adherence with the guidelines for prescribing antipsychotics and the monitoring of metabolic effects in this population. We collected the available retrospective data (socio-demographic, psychiatric, anthropometric, and metabolic measures) from the records of 439 patients maintained on antipsychotics. The majority were males, married, employed, having a psychotic disorder, and receiving SGA. Patients on SGA showed more obesity, higher BP, and more elevated triglycerides compared to those on FGA. The prevalence of the abnormal metabolic measures was high in this sample, but those on SGA showed a significantly higher prevalence of abnormal body mass index and BP. Obesity and hypertension were common in patients maintained on antipsychotics, especially those on SGA. Polypharmacy was common, and many metabolic measures were not monitored properly in those maintained on antipsychotics. More prospective studies with guided monitoring of the patients' clinical status and metabolic changes are needed to serve better this population of patients.</p><h2>Other Information</h2> <p> Published in: Community Mental Health Journal<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s10597-019-00537-y" target="_blank">http://dx.doi.org/10.1007/s10597-019-00537-y</a></p>2022-11-22T21:13:03ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s10597-019-00537-yhttps://figshare.com/articles/journal_contribution/Risk_Factors_of_Metabolic_Syndrome_Among_Patients_Receiving_Antipsychotics_A_Retrospective_Study/21597216CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/215972162022-11-22T21:13:03Z
spellingShingle Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
Samer Hammoudeh (3095097)
Clinical sciences
Public health
Psychiatry and Mental health
Public Health, Environmental and Occupational Health
Health (social science)
status_str publishedVersion
title Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
title_full Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
title_fullStr Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
title_full_unstemmed Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
title_short Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
title_sort Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
topic Clinical sciences
Public health
Psychiatry and Mental health
Public Health, Environmental and Occupational Health
Health (social science)